Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospitals Having Difficulty Getting Medical Equipment Y2K Compliance Info

This article was originally published in The Gray Sheet

Executive Summary

As of July, 49% of the nation's hospitals reported having problems obtaining information from manufacturers on the year 2000 readiness of their biomedical equipment, according to a survey released Oct. 5 by the HHS Office of the Inspector General.

You may also be interested in...



GAO Optimistic About FDA Y2K Readiness Measures For High-Risk Devices

The General Accounting Office has a higher level of confidence in year 2000 readiness of high-risk medical devices than it did roughly five months ago, GAO Civil Agencies Information Systems Accounting and Information Management Division Director Joel Willemssen said.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel